These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36032071)

  • 1. Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates.
    Guo C; Tang Y; Yang Z; Li G; Zhang Y
    Front Immunol; 2022; 13():958161. PubMed ID: 36032071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.
    Tang Y; Guo C; Yang Z; Wang Y; Zhang Y; Wang D
    Front Immunol; 2022; 13():862527. PubMed ID: 35493471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a vesicle-mediated transport-associated gene signature for predicting prognosis and immune therapy response in hepatocellular carcinoma.
    Liu ZY; Li YH; Li BW; Xin L
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13211-13230. PubMed ID: 37479759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma.
    Guo C; Tang Y; Li Q; Yang Z; Guo Y; Chen C; Zhang Y
    Comput Biol Med; 2023 May; 158():106872. PubMed ID: 37030269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
    Wang T; Dai L; Shen S; Yang Y; Yang M; Yang X; Qiu Y; Wang W
    Front Immunol; 2022; 13():843408. PubMed ID: 35693827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues.
    Gong J; Li R; Chen Y; Zhuo Z; Chen S; Cao J; Zhang Q; Chong Y; Hu B
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33515024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.
    Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z
    Front Genet; 2021; 12():717319. PubMed ID: 34899826
    [No Abstract]   [Full Text] [Related]  

  • 11. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a signature based on immunogenic cell death-related gene pairs to predict immunotherapy and survival outcomes of patients with hepatocellular carcinoma.
    Ma J; Kuang L; Zhao R
    Aging (Albany NY); 2022 Dec; 14(23):9699-9714. PubMed ID: 36516498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
    Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R
    Front Immunol; 2022; 13():856186. PubMed ID: 35479067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients.
    Lv W; Yao Q
    Dis Markers; 2022; 2022():9428660. PubMed ID: 35069936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.
    Lei J; Zhang D; Yao C; Ding S; Lu Z
    Cancer Control; 2020; 27(1):1073274820977114. PubMed ID: 33269615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.
    Chen B; Yang Z; Lang Z; Tao Q; Zhang R; Zhan Y; Xu X; Zhu K; Zheng J; Yu Z; Yu S
    BMC Cancer; 2022 Aug; 22(1):867. PubMed ID: 35941582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.